Leadership

Zeffy Karagiannakis is a strategic pharmaceutical marketing leader and consultant with extensive experience developing brand strategies that drive measurable growth across the full pharmaceutical product lifecycle. She specializes in helping pharmaceutical companies translate complex scientific innovation into clear, effective marketing strategies that resonate with healthcare professionals, patients, and key stakeholders.

Throughout her career, Zeffy has led the development of robust, award-winning market strategies designed to accelerate brand development, expand market share, and deliver strong commercial performance while optimizing marketing investment. Her work focuses on aligning marketing initiatives with broader business objectives, ensuring that strategic programs deliver both market impact and measurable return on investment.

Her expertise spans brand lifecycle management—from pre-launch planning through growth, maturity, and loss of exclusivity (LOE)—supporting pharmaceutical organizations in navigating complex market environments. Zeffy has extensive experience designing integrated omni-channel marketing programs that engage healthcare professionals, consumers, and key stakeholders across multiple platforms and channels.

Known for her collaborative leadership style, Zeffy works closely with cross-functional teams across commercial, medical, regulatory, and market access functions to develop strategic initiatives that support successful product launches and sustained brand growth. Her approach emphasizes data-driven decision making, operational efficiency, and strong stakeholder relationships to ensure programs are both impactful and scalable.

Zeffy’s experience spans multiple therapeutic areas including oncology, rare disease, women’s health, neurology, endocrinology, and vaccines, providing her with a broad perspective on healthcare markets and patient needs. She brings an entrepreneurial mindset, analytical rigor, and passion for marketing innovation to every engagement, helping organizations build stronger brands and achieve meaningful growth in competitive pharmaceutical markets.